These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 31866529)
1. Effect of frequency of sensor use on glycaemic control in individuals on sensor-augmented pump therapy with and without Predictive Low Glucose Management System. Abraham MB; Smith GJ; Nicholas JA; Fairchild JM; King BR; Ambler GR; Cameron FJ; Davis EA; Jones TW; Diabetes Res Clin Pract; 2020 Jan; 159():107989. PubMed ID: 31866529 [TBL] [Abstract][Full Text] [Related]
2. The Incremental Benefits of the Predictive Low-Glucose Suspend Function Compared to the Low-Glucose Suspend Function as Automation Against Hypoglycemia in Sensor-Augmented Pump Therapy. Beato-Víbora PI; Gil-Poch E; Galán-Bueno L; Lázaro-Martín L; Arroyo-Díez FJ J Diabetes Sci Technol; 2018 Nov; 12(6):1241-1243. PubMed ID: 30058373 [No Abstract] [Full Text] [Related]
3. Reduction in Hypoglycemia With the Predictive Low-Glucose Management System: A Long-term Randomized Controlled Trial in Adolescents With Type 1 Diabetes. Abraham MB; Nicholas JA; Smith GJ; Fairchild JM; King BR; Ambler GR; Cameron FJ; Davis EA; Jones TW; Diabetes Care; 2018 Feb; 41(2):303-310. PubMed ID: 29191844 [TBL] [Abstract][Full Text] [Related]
4. Use of sensor-integrated pump therapy to reduce hypoglycaemia in people with Type 1 diabetes: a real-world study in the UK. Choudhary P; de Portu S; Arrieta A; Castañeda J; Campbell FM Diabet Med; 2019 Sep; 36(9):1100-1108. PubMed ID: 31134668 [TBL] [Abstract][Full Text] [Related]
5. Faster insulin action is associated with improved glycaemic outcomes during closed-loop insulin delivery and sensor-augmented pump therapy in adults with type 1 diabetes. Ruan Y; Thabit H; Leelarathna L; Hartnell S; Wilinska ME; Tauschmann M; Dellweg S; Benesch C; Mader JK; Holzer M; Kojzar H; Evans ML; Pieber TR; Arnolds S; Hovorka R; Diabetes Obes Metab; 2017 Oct; 19(10):1485-1489. PubMed ID: 28371223 [TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of sensor-augmented pump therapy (SAPT) with predictive low-glucose management in patients diagnosed with type 1 diabetes mellitus previously treated with SAPT and low glucose suspend. Gómez AM; Henao DC; Imitola A; Muñoz OM; Sepúlveda MAR; Kattah L; Guerrero JS; Morros E; Llano JP; Jaramillo MG; León-Vargas F Endocrinol Diabetes Nutr (Engl Ed); 2018 Oct; 65(8):451-457. PubMed ID: 29914817 [TBL] [Abstract][Full Text] [Related]
7. In-Clinic Evaluation of the MiniMed 670G System "Suspend Before Low" Feature in Children with Type 1 Diabetes. Wood MA; Shulman DI; Forlenza GP; Bode BW; Pinhas-Hamiel O; Buckingham BA; Kaiserman KB; Liljenquist DR; Bailey TS; Shin J; Huang S; Chen X; Cordero TL; Lee SW; Kaufman FR Diabetes Technol Ther; 2018 Nov; 20(11):731-737. PubMed ID: 30299976 [TBL] [Abstract][Full Text] [Related]
8. Effect of predicted low suspend pump treatment on improving glycaemic control and quality of sleep in children with type 1 diabetes and their caregivers: the QUEST randomized crossover study. Schierloh U; Aguayo GA; Fichelle M; De Melo Dias C; Celebic A; Vaillant M; Barnard K; Cohen O; de Beaufort C Trials; 2018 Dec; 19(1):665. PubMed ID: 30509293 [TBL] [Abstract][Full Text] [Related]
10. Glucose-responsive insulin delivery for type 1 diabetes: The artificial pancreas story. Bally L; Thabit H; Hovorka R Int J Pharm; 2018 Jun; 544(2):309-318. PubMed ID: 29258910 [TBL] [Abstract][Full Text] [Related]
11. Night glucose control with MD-Logic artificial pancreas in home setting: a single blind, randomized crossover trial-interim analysis. Nimri R; Muller I; Atlas E; Miller S; Kordonouri O; Bratina N; Tsioli C; Stefanija MA; Danne T; Battelino T; Phillip M Pediatr Diabetes; 2014 Mar; 15(2):91-9. PubMed ID: 23944875 [TBL] [Abstract][Full Text] [Related]
12. Impact of Sensor-Augmented Pump Therapy with Predictive Low-Glucose Suspend Function on Glycemic Control and Patient Satisfaction in Adults and Children with Type 1 Diabetes. Beato-Víbora PI; Quirós-López C; Lázaro-Martín L; Martín-Frías M; Barrio-Castellanos R; Gil-Poch E; Arroyo-Díez FJ; Giménez-Álvarez M Diabetes Technol Ther; 2018 Nov; 20(11):738-743. PubMed ID: 30256132 [TBL] [Abstract][Full Text] [Related]
13. Prevention of Hypoglycemia With Predictive Low Glucose Insulin Suspension in Children With Type 1 Diabetes: A Randomized Controlled Trial. Battelino T; Nimri R; Dovc K; Phillip M; Bratina N Diabetes Care; 2017 Jun; 40(6):764-770. PubMed ID: 28351897 [TBL] [Abstract][Full Text] [Related]
14. The accuracy and efficacy of real-time continuous glucose monitoring sensor in Chinese diabetes patients: a multicenter study. Zhou J; Lv X; Mu Y; Wang X; Li J; Zhang X; Wu J; Bao Y; Jia W Diabetes Technol Ther; 2012 Aug; 14(8):710-8. PubMed ID: 22853722 [TBL] [Abstract][Full Text] [Related]
15. Prevention of Insulin-Induced Hypoglycemia in Type 1 Diabetes with Predictive Low Glucose Management System. Abraham MB; de Bock M; Paramalingam N; O'Grady MJ; Ly TT; George C; Roy A; Spital G; Karula S; Heels K; Gebert R; Fairchild JM; King BR; Ambler GR; Cameron F; Davis EA; Jones TW Diabetes Technol Ther; 2016 Jul; 18(7):436-43. PubMed ID: 27148807 [TBL] [Abstract][Full Text] [Related]
16. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial. Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967 [TBL] [Abstract][Full Text] [Related]
17. "Let the Algorithm Do the Work": Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients. Biester T; Kordonouri O; Holder M; Remus K; Kieninger-Baum D; Wadien T; Danne T Diabetes Technol Ther; 2017 Mar; 19(3):173-182. PubMed ID: 28099035 [TBL] [Abstract][Full Text] [Related]
18. Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial. Forlenza GP; Li Z; Buckingham BA; Pinsker JE; Cengiz E; Wadwa RP; Ekhlaspour L; Church MM; Weinzimer SA; Jost E; Marcal T; Andre C; Carria L; Swanson V; Lum JW; Kollman C; Woodall W; Beck RW Diabetes Care; 2018 Oct; 41(10):2155-2161. PubMed ID: 30089663 [TBL] [Abstract][Full Text] [Related]
19. Sensor-augmented pump therapy from the diagnosis of childhood type 1 diabetes: results of the Paediatric Onset Study (ONSET) after 12 months of treatment. Kordonouri O; Pankowska E; Rami B; Kapellen T; Coutant R; Hartmann R; Lange K; Knip M; Danne T Diabetologia; 2010 Dec; 53(12):2487-95. PubMed ID: 20711715 [TBL] [Abstract][Full Text] [Related]
20. Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial. Ly TT; Nicholas JA; Retterath A; Lim EM; Davis EA; Jones TW JAMA; 2013 Sep; 310(12):1240-7. PubMed ID: 24065010 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]